SCHEMBL7903541

SCHEMBL7903541

CC1NCc2cccc([N+](=O)[O-])c2NC1C

nearest known ligand 0.40

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.40
PNMT P11086 6/20 0.38
ADRA2A P08913 1/20 0.38
ADRA2B P18089 1/20 0.38
ADRA2C P18825 1/20 0.38
CHRNB2 P17787 1/20 0.37
CHRNA4 P43681 1/20 0.37
ACHE P22303 1/20 0.37
TSHR P16473 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
GPR35 Q9HC97 1/20 0.36
NR4A1 P22736 1/20 0.36
HSD17B10 Q99714 2/20 0.36
TXNRD1 Q16881 1/20 0.36
TXNRD3 Q86VQ6 1/20 0.36
TXNRD2 Q9NNW7 1/20 0.36
ALDH1A1 P00352 1/20 0.36
CYP3A4 P08684 1/20 0.36
ALOX15 P16050 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9539807 0.78 PNMT (0.43) TDP1PNMTADRA2AADRA2BADRA2C
SCHEMBL9539813 0.78 PNMT (0.43) TDP1PNMTADRA2AADRA2BADRA2C
SCHEMBL27609029 0.77 TDP1 (0.43) TDP1PNMTADRA2AADRA2BADRA2C
SCHEMBL10841429 0.75 TDP1 (0.41) TDP1PNMTCHRNB2CHRNA4ACHE
SCHEMBL7896203 0.73 S100A4 (0.45) TDP1TSHRSMN1; SMN2GPR35HSD17B10
SCHEMBL7896197 0.73 S100A4 (0.45) TDP1TSHRSMN1; SMN2GPR35HSD17B10
SCHEMBL7908209 0.73 S100A4 (0.45) TDP1TSHRSMN1; SMN2GPR35HSD17B10
SCHEMBL7896207 0.73 S100A4 (0.45) TDP1TSHRSMN1; SMN2GPR35HSD17B10
SCHEMBL7908204 0.73 S100A4 (0.45) TDP1TSHRSMN1; SMN2GPR35HSD17B10
SCHEMBL17257605 0.72 TDP1 (0.44) TDP1TSHRSMN1; SMN2GPR35NR4A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6201119-B1 2,3,4,5-TETRAHYDRO-1H-1,4-BENZODIAZEPIN-9-AMINE COMPOUNDS USEFUL AS INTERMEDIATES TO ANTIVIRALS JANSSEN PHARMACEUTICA N.V. (BE) 2001-03-13 US disclosed
US-5371079-A Administering to inhibit replication of HIV-1 in human cells JANSSEN PHARMACEUTICA N.V. (BE) 1994-12-06 US disclosed
US-5270464-A Anti-HIV-1 tetrahydroimidazo[1,4]benzodiazepin-2-(thi) ones JANSSEN PHARMACEUTICA N.V. (BE) 1993-12-14 US disclosed